跳至主要内容
临床试验/CTRI/2024/12/078529
CTRI/2024/12/078529尚未招募2/3 期

Open randomized control clinical trial of yashtimadhu sita churna with tandulodak in raktapradar with special reference to menorrhagia

Dr Sharayu Laxmanrao Raut1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2024年12月28日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
68
试验地点
1
主要终点
Yashtimadhu Sita Churna With Tadulodak Is Effective In The Management Of Raktapradar

研究概览

简要总结

Female reproductive system has a great importance and any disease related to this system will seriously affect womens health and happiness and proves to be great discomfort.now a day due to changing life style and food habits complain of the excessive uterine bleeding is increasing day by day .many side effects have been observed because of modern medication and hysterectomy leading to  hormonal imbalance and psychological upset in young fertile women.so keeping mind i took Ayurvedic drug Yahtimadhu sita churna with tandulodak from 1st day of 1st menstural cycle of treatment and will be continued for consecutive 90 days  which is non hormonal and safe that could provide effective treatment on raktapradar.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Patients fulfilling Diagnostic criteria Patient Having Heavy menstruation with Duration of Bleeding More Than 7 days or Amount of Bleeding More Than 80ml or both at least Two Consecutive cycle.
  • Patients having regular menstrual cycle.
  • Patients having uterine fibroid size less than or equal to 4cm and fibroid measuring 4 cm only 3 fibroid will be included.Patient having HB More Than 7 gm % Included.

排除标准

  • 1 Patient Having Congenital Anomaly Of Reprductive System 2 Pregnant Women 3 Patients With Post Menopausal Bleeding And Intra Uterine Devices 4 Known Case Of DM Malignancy Coagulopathy 5 Uncontrolled HTN.

结局指标

主要结局

Yashtimadhu Sita Churna With Tadulodak Is Effective In The Management Of Raktapradar

时间窗: 90 Days

次要结局

  • Combined Oral Contraceptive Pills(Tab Ovral-L) Is Effective In The Management Of Raktapradar(12 Weeks)

研究者

发起方
Dr Sharayu Laxmanrao Raut
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Sharayu Raut

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta

研究点 (1)

Loading locations...

相似试验